Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing

NIH RePORTER · NIH · R44 · $745,488 · view on reporter.nih.gov ↗

Key facts

NIH application ID
10183319
Project number
5R44HL149566-03
Recipient
CURI BIO INC
Principal Investigator
Nicholas Andrew Geisse
Activity code
R44
Funding institute
NIH
Fiscal year
2021
Award amount
$745,488
Award type
5
Project period
2019-09-01 → 2023-05-31